Major Biotech ETFs Had Lackluster Performance in the Past Month

All three major biotechnology ETFs—the SPDR S&P Biotech ETF (XBI), the iShares NASDAQ Biotechnology Index (IBB), and the ProShares Ultra Nasdaq Biotechnology ETF (BIB)—have posted returns of ~1% in last month, starting on August 10. That compares unfavorably with the performance of the SPDR S&P 500 ETF (SPY), which returned ~1.7% in the same period.

Source: Major Biotech ETFs Had Lackluster Performance in the Past Month

Theranos finally shutting down

Creative Biotech has been covering the blood testing industry and scams infesting it for a couple of years. Tap the image to go to the “In-Focus” page for the complete story.

SQUAWK BOX — Elizabeth Holmes, Theranos CEO and the world’s youngest self-made female billionaire, in an interview on September 29, 2015 — (Photo by: David Orrell/CNBC/NBCU Photo Bank via Getty Images)

TD Ameritrade: Biotech Could Be Tariff Proof

Biotech stocks have been holding up relatively well this year even as talk of trade wars ramps up, in part because of the sector’s insulation to tariffs. Tap the image below for the entire article, published on the “Investopedia” web site.